Hans Schikan joins Khondrion’s Advisory Board

Khondrion

10/8/15 - Khondrion, the Dutch biopharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, announces today that Hans Schikan, former CEO of Prosensa, has joined Khondrion’s Advisory Board. Read the full press release.
 

Search Results